PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism

Y Tan, Y Jin, X Wu, Z Ren - BMC Molecular Biology, 2019 - Springer
Background Obesity and nonalcoholic steatohepatitis (NASH) are well-known risk factors of
hepatocellular carcinoma (HCC). The lipid-rich environment enhances the proliferation and …

Dysfunction of IKZF1/MYC/MDIG axis contributes to liver cancer progression through regulating H3K9me3/p21 activity

Q Huo, C Ge, H Tian, J Sun, M Cui, H Li, F Zhao… - Cell Death & …, 2017 - nature.com
MDIG is known to be overexpressed in many types of human cancers and has demonstrated
predictive power in the prognosis of cancer, although the functions and mechanisms of …

[HTML][HTML] Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms

R Stad, NA Little, DP Xirodimas, R Frenk… - EMBO …, 2001 - embopress.org
The p53 protein maintains genomic integrity through its ability to induce cell cycle arrest or
apoptosis in response to various forms of stress. Substantial regulation of p53 activity occurs …

A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma

SL Chen, CZ Zhang, LL Liu, SX Lu, YH Pan, CH Wang… - Cancer research, 2019 - AACR
Hepatocellular carcinogenesis is attributed to the reprogramming of cellular metabolism as a
consequence of the alteration in metabolite-related gene regulation. Identifying the …

[HTML][HTML] Regulation of p53: a collaboration between Mdm2 and Mdmx

D Pei, Y Zhang, J Zheng - Oncotarget, 2012 - ncbi.nlm.nih.gov
Abstract p53 plays an important role in the regulation of the cell cycle, DNA repair, and
apoptosis and is an attractive cancer therapeutic target. Mdm2 and Mdmx are recognized as …

p53-independent effects of Mdm2

S Bohlman, JJ Manfredi - Mutant p53 and MDM2 in Cancer, 2014 - Springer
Mdm2 is best known as the primary negative regulator of p53, but a growing body of
evidence suggests that Mdm2 also has a number of functions independent of its role in …

[HTML][HTML] Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer

M Dong, G Ma, W Tu, KJ Guo, YL Tian… - World journal of …, 2005 - ncbi.nlm.nih.gov
AIM: To study the clinicopathological significance of p53 and mdm2 protein expression in
human pancreatic cancer. METHODS: To investigate the expression of p53 and mdm2 in …

[HTML][HTML] MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway

Y Yao, C Dou, Z Lu, X Zheng, Q Liu - Cellular Physiology and …, 2015 - karger.com
Background & Aims: To investigate the expression and prognostic value of MACC1 in
patients with HCC and identify the mechanism by which MACC1 inhibits HCC cell apoptosis …

A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma.

M Jablkowski, A Bocian, J Bialkowska… - … of experimental & …, 2005 - europepmc.org
In the present study, the expression of P53 and MDM2 proteins were examined in
specimens from a group of 20 patients (9 with primary hepatocellular carcinoma HCC and …

Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma

K Endo, T Ueda, T Ohta, T Terada - Liver, 2000 - Wiley Online Library
Background/Aims: The transcription of mdm2 gene is activated by p53 and this limits the
growth‐suppressing activity of p53 by direct binding. It has been reported that MDM2 protein …